S-aryl cysteine S,S-dioxides as inhibitors of mammalian kynureninase

被引：20

作者：

Drysdale, MJ

Reinhard, JF

机构：

[1] Glaxo Wellcome Res & Dev Ltd, Combinatorial Med Chem, Stevenage SG1 2NY, Herts, England

[2] Glaxo Wellcome Inc, Res & Dev, Dept Pharmacol, Res Triangle Pk, NC 27709 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 02期

关键词：

D O I：

10.1016/S0960-894X(97)10209-8

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of 2-amino-S-aryl cysteine S,S-dioxides have been synthesised and shown to inhibit kynureninase an important enzyme in the biosynthesis of the known excitotoxic moiety quinolinic acid. The most potent of these, 2-amino-5-methyl-S-phenyl cysteine S,S-dioxide 6d, inhibits interferon-gamma induced synthesis of quinolinic acid in human macrophages. (C) 1998 Elsevier Science Ltd. All rights reserved.

引用

收藏

页码：133 / 138

页数：6

相关论文

共 17 条

[1] QUINOLINIC ACID ACCUMULATION AND FUNCTIONAL DEFICITS FOLLOWING EXPERIMENTAL SPINAL-CORD INJURY [J].

BLIGHT, AR ;

COHEN, TI ;

SAITO, K ;

HEYES, MP .

BRAIN, 1995, 118 :735-752

[2]

CHIARUGI A, 1995, J NEUROCHEM, V65, P1176

[3] S-ARYL-L-CYSTEINE S,S-DIOXIDES - DESIGN, SYNTHESIS, AND EVALUATION OF A NEW CLASS OF INHIBITORS OF KYNURENINASE [J].

DUA, RK ;

TAYLOR, EW ;

PHILLIPS, RS .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (04) :1264-1270

[4] QUINOLINIC ACID IN CEREBROSPINAL-FLUID AND SERUM IN HIV-1 INFECTION - RELATIONSHIP TO CLINICAL AND NEUROLOGICAL STATUS [J].

HEYES, MP ;

BREW, BJ ;

MARTIN, A ;

PRICE, RW ;

SALAZAR, AM ;

SIDTIS, JJ ;

YERGEY, JA ;

MOURADIAN, MM ;

SADLER, AE ;

KEILP, J ;

RUBINOW, D ;

MARKEY, SP .

ANNALS OF NEUROLOGY, 1991, 29 (02) :202-209

[5] QUINOLINIC ACID AND KYNURENINE PATHWAY METABOLISM IN INFLAMMATORY AND NONINFLAMMATORY NEUROLOGICAL DISEASE [J].

HEYES, MP ;

SAITO, K ;

CROWLEY, JS ;

DAVIS, LE ;

DEMITRACK, MA ;

DER, M ;

DILLING, LA ;

ELIA, J ;

KRUESI, MJP ;

LACKNER, A ;

LARSEN, SA ;

LEE, K ;

LEONARD, HL ;

MARKEY, SP ;

MARTIN, A ;

MILSTEIN, S ;

MOURADIAN, MM ;

PRANZATELLI, MR ;

QUEARRY, BJ ;

SALAZAR, A ;

SMITH, M ;

STRAUSS, SE ;

SUNDERLAND, T ;

SWEDO, SW ;

TOURTELLOTTE, WW .

BRAIN, 1992, 115 :1249-1273

[6] QUANTIFICATION OF QUINOLINIC ACID IN RAT-BRAIN, WHOLE-BLOOD, AND PLASMA BY GAS-CHROMATOGRAPHY AND NEGATIVE CHEMICAL IONIZATION MASS-SPECTROMETRY - EFFECTS OF SYSTEMIC L-TRYPTOPHAN ADMINISTRATION ON BRAIN AND BLOOD QUINOLINIC ACID CONCENTRATIONS [J].

HEYES, MP ;

MARKEY, SP .

ANALYTICAL BIOCHEMISTRY, 1988, 174 (01) :349-359

[7] HUMAN MACROPHAGES CONVERT L-TRYPTOPHAN INTO THE NEUROTOXIN QUINOLINIC ACID [J].

HEYES, MP ;

SAITO, K ;

MARKEY, SP .

BIOCHEMICAL JOURNAL, 1992, 283 :633-635

[8]

MARTIN A, 1992, J NEUROPSYCH CLIN N, V4, P270

[9] SYNTHESIS AND ACTIVITY OF ENANTIOPURE (S)(M-NITROBENZOYL) ALANINE, POTENT KYNURENINE-3-HYDROXYLASE INHIBITOR [J].

NATALINI, B ;

MATTOLI, L ;

PELLICCIARI, R ;

CARPENEDO, R ;

CHIARUGI, A ;

MORONI, F .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (14) :1451-1454

[10] The regulation of quinolinic acid in human immunodeficiency virus-infected monocytes [J].

Nottet, HSLM ;

Flanagan, EM ;

Flanagan, CR ;

Gelbard, HA ;

Gendelman, HE ;

Reinhard, JF .

JOURNAL OF NEUROVIROLOGY, 1996, 2 (02) :111-117